Roth Capital Affirms BioLineRx (BLRX) at 'Buy' Following BL-8040 Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
| BIOLINE RX SP ADR (NASDAQ: BLRX) | Delayed: 2.03 +0.02 (1.00%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.01 | 52 Week High | $1.63 | |||
| Open | $1.97 | 52 Week Low | $0.71 | |||
| Day High | $2.03 | P/E | N/A | |||
| Day Low | $1.96 | EPS | $0.00 | |||
| Volume | 4,992 | |||||
